- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Postprandial Glucose Response in Korea, Democratic People's Republic of
Total 795 results
-
University of Banja LukaEnrolling by invitationDiabetes Mellitus, Type 2Bosnia and Herzegovina
-
Novo Nordisk A/SEnrolling by invitation
-
Birjand University of Medical SciencesCompletedHyperglycemia | Metabolic Syndrome | Hypercholesterolemia | HypertriglyceridemiaIran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Shiraz University of Medical SciencesCompletedDiabetes Mellitus, Type 2 | Fatty LiverIran, Islamic Republic of
-
Shiraz University of Medical SciencesCompletedDiabetes Mellitus, Type 2 | Sleep DisturbanceIran, Islamic Republic of
-
National Nutrition and Food Technology InstituteCompletedType 2 Diabetes Nonalcoholic Fatty LiverIran, Islamic Republic of
-
International Diabetes Institute, AustraliaGlaxoSmithKlineCompletedType 2 Diabetes MellitusChina, Indonesia, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
Tehran University of Medical SciencesCompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | Essential HypertensionIran, Islamic Republic of
-
Alborz Medical UniversityUniversiti Putra MalaysiaCompletedVitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, IranHypertension | Diabetes Mellitus | Vitamin D Deficiency | Lipid Metabolism Disorders | Obesity, AbdominalIran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Shiraz University of Medical SciencesCompletedDiabetic Nephropathy | Chronic Kidney Disease | Diabetes Type 2Iran, Islamic Republic of
-
University of Sistan and BaluchestanNiloofar Zareie Mohammad ZadehCompletedMetabolic Syndrome | Non-alcoholic Fatty Liver Disease | Women's Health | Middle Aged | Hybrid TrainingIran, Islamic Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
National Nutrition and Food Technology InstituteUnknownMetabolic SyndromeIran, Islamic Republic of
-
National Nutrition and Food Technology InstituteUnknownMetabolic SyndromeIran, Islamic Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Korea, Republic of, Hungary, Canada, Australia
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
PfizerCompletedCandidiasisUnited States, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Israel, Korea, Republic of, Turkey, Italy, Belgium, United Kingdom, Greece, Ireland, Sweden, Denmark, Finland, France, Czech Republic
-
Novo Nordisk A/SCompleted
-
PfizerCompletedCandidemiaUnited States, Taiwan, Spain, United Kingdom, Korea, Republic of, Brazil, Greece, Canada, Italy, Russian Federation
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
University Medicine GreifswaldEuropean Society of Intensive Care Medicine; Becton, Dickinson and Company; European... and other collaboratorsCompletedSepsisNetherlands, Norway, Belgium, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Moldova, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
TakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 1France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Korea, Republic of, China, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
SanofiCompletedDiabetes Mellitus, Type 2United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Taiwan, Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Bristol-Myers SquibbCompletedDiabetes Type 2United States, Canada, Korea, Republic of, Australia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Korea, Republic of, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusChina, India, Korea, Republic of, Russian Federation